News und Analysen
Quidel Supports New NIH, CDC Public Health Initiative for At-home COVID-19 Testing
Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it is
Quidel’s QuickVue® At-Home OTC COVID-19 Test Receives Emergency Use Authorization for Screening Use With Serial Testing
Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it has
Pfizer-BioNTech Announce Positive Topline Results of Pivotal COVID-19 Vaccine Study in Adolescents
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that, in a Phase 3 trial in adolescents 12 to 15 years of age with or without prior evidence of SARS-CoV-2 infection, the
Illumina Committed to Pursuing GRAIL Acquisition to Accelerate Access to Breakthrough Multi-Cancer Early Detection Blood Test
Illumina, Inc. (NASDAQ: ILMN), today announced that it disagrees with, and will oppose, the U.S. Federal Trade Commission (FTC)’s challenge to its previously announced acquisition of GRAIL, a
Humana Healthy Horizons Partners with GoNoodle® to Boost Physical and Mental Health for 2.4 Million Kids
Humana Healthy Horizons, the Medicaid business of leading health and well-being company Humana Inc. (NYSE: HUM), announced a partnership with GoNoodle®, an interactive mindfulness and physical
Agilent Awards Octagon Therapeutics with a Golden Ticket at LabCentral
Agilent Technologies Inc. (NYSE: A) announces that Octagon Therapeutics has been awarded an Agilent Golden Ticket at LabCentral. The Golden Ticket was presented to Octagon during a virtual online
TFS HealthScience standardisiert Arbeit mit Veeva Vault Clinical Operations Suite, um klinische Entwicklung zu beschleunigen
Veeva Systems (NYSE: VEEV) hat heute bekanntgegeben, dass sich TFS HealthScience für die Veeva Vault Clinical Operations Suite entschieden hat, um das End-to-End-Management von Studien auf einer
Joint FDA Advisory Committee Votes on Application for Tanezumab for the Treatment of Osteoarthritis Pain
Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) today announced the outcome of the U.S. Food and Drug Administration (FDA) Joint Arthritis Advisory Committee and Drug Safety and Risk
TFS HealthScience Standardizes on Veeva Vault Clinical Operations Suite to Accelerate Clinical Development
Veeva Systems (NYSE: VEEV) today announced that TFS HealthScience selected Veeva Vault Clinical Operations Suite for end-to-end study management on a single cloud platform. The global CRO is taking
TFS HealthScience Standardizes on Veeva Vault Clinical Operations Suite to Accelerate Clinical Development
Veeva Systems (NYSE: VEEV) today announced that TFS HealthScience selected Veeva Vault Clinical Operations Suite for end-to-end study management on a single cloud platform. The global CRO is taking
Real-World Evidence Supports Effectiveness of First-line IBRANCE® (palbociclib) Combination Therapy in HR+, HER2- Metastatic Breast Cancer
Pfizer Inc. (NYSE:PFE) today announced the peer-reviewed publication of real-world evidence (RWE) demonstrating that first-line therapy with IBRANCE® (palbociclib) in combination with letrozole was
Boehringer Ingelheim vollzieht mit Veeva CRM Engage Meeting einen schnellen Übergang zur digitalen Interaktion
Boehringer Ingelheim, ein globales Top-20-Pharmaunternehmen, setzt standardmäßig auf Veeva CRM Engage Meeting, um die Interaktionen zwischen seiner globalen Außendienstorganisation und
The Humana Foundation Awards Nearly $1 Million in a Second Year Investment to Kingsley House and Growing Local Food Collaborative
The Humana Foundation, philanthropic arm of Humana Inc. (NYSE: HUM) for the past 40 years, announces its second year of investments, totaling nearly $1 million in two local projects in the greater
Epic and Humana Deliver on Commitment to Enhance Connectivity and Collaboration Among Patients, Providers, and Health Plans
Humana Inc. (NYSE: HUM), a leading health and well-being company, and Epic, developer of the nation’s most widely used comprehensive health record, have completed the first stage of a joint effort
Boehringer Ingelheim Makes Rapid Shift to Digital Engagement with Veeva CRM Engage Meeting
Boehringer Ingelheim, a top 20 global pharmaceutical company, is standardizing on Veeva CRM Engage Meeting to drive more valued interactions between its global field organization and healthcare
Boehringer Ingelheim Makes Rapid Shift to Digital Engagement with Veeva CRM Engage Meeting
Boehringer Ingelheim, a top 20 global pharmaceutical company, is standardizing on Veeva CRM Engage Meeting to drive more valued interactions between its global field organization and healthcare
Pfizer Initiates Phase 1 Study of Novel Oral Antiviral Therapeutic Agent Against SARS-CoV-2
Pfizer Inc. (NYSE: PFE) announced today that it is progressing to multiple ascending doses after completing the dosing of single ascending doses in a Phase 1 study in healthy adults to evaluate the
Humana Adds H Mart to List of National Retailers for Healthy Foods Card Benefit
Humana Inc. (NYSE: HUM), one of the nation’s leading health and well-being companies and H Mart, the largest Asian supermarket chain in the U.S., announced today a collaboration to combat food
Pfizer Invites Public to View and Listen to Webcast of Pfizer May 4 Conference Call with Analysts
Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Tuesday, May 4, 2021. The purpose of
Dexcom Promotes Jereme Sylvain to Chief Financial Officer
DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring, today announced the promotion of Jereme Sylvain to the role of Executive Vice President and Chief
Quidel Corporation Applauds Biden Administration Plan to Expand COVID-19 Testing
Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, today announced its support for the
Illumina Announces Board Changes
Illumina, Inc. (NASDAQ: ILMN) (the “Company”) today announced that Jay Flatley has decided to step down from the Board of Directors and John W. Thompson will be appointed as the Company’s new Chair
Waters Peptide Multi-Attribute Method for BioAccord System Boosts Innovator and Biosimilar Drug Development and Commercialization
Waters Corporation (NYSE:WAT) today introduced a new peptide multi-attribute method (MAM) workflow for the Waters™ BioAccord™ LC-MS System, enabling drug development, manufacturing, and QC
Agilent Announces Cash Dividend of 19.4 Cents per Share
Agilent Technologies, Inc. (NYSE: A) today announced that a quarterly dividend of 19.4 cents per share of common stock will be paid on April 28, 2021, to all shareholders of record as of the close
Der erste Patient schließt in Phase IIb die digitale Einwilligung mit dem Veeva Clinical Network ab
Veeva Systems (NYSE: VEEV) gab heute bekannt, dass Veeva eConsent, eine MyVeeva for Patients-Anwendung, die auf dem Veeva Clinical Network basiert, von seinem ersten Patienten eine elektronische